-
Adolescents prefer long-acting injectables to daily oral treatment, study finds
27 Mar 2024 14:04 GMT
… tolerability means that drug side-effects do … medication reduced the burden of receiving HIV treatment by:
having the medical … injection treatment is not so stressful”
“I hate pills … LA Cabotegravir Plus Rilpivirine for HIV Treatment. Conference on …
-
Injectable HIV treatment, prevention: Everything you need to know
26 Mar 2024 19:45 GMT
… HIV available in the U.S. A combination of cabotegravir and rilpivirine … to take a daily pill. For many, stopping … . Talk to your doctor about Apretude if you … HIV Drug Resistance
There are also some FDA-approved injectable drugs designed to help treatment …
-
U.S. FDA approves EDURANT PED for pediatric patients living with HIV-1
26 Mar 2024 12:11 GMT
… and Drug Administration (FDA) has approved Johnson & Johnson’s EDURANT® PED (rilpivirine … ) for the treatment of HIV-1 in combination with … Area Head, Infectious Diseases and Vaccines at Johnson & Johnson.
“While …
-
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
26 Mar 2024 12:00 GMT
… room TVs in doctor offices, and … Food and Drug Administration (FDA)-approved treatment of its … medicine that contains rilpivirine (EDURANT, COMPLERA, JULUCA, ODEFSEY, CABENUVA) used to treat HIV … Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a …
-
Top 5 stories on injectable HIV treatment and PrEP from CROI 2024
25 Mar 2024 07:08 GMT
… injectable HIV treatment and PrEP (medication to prevent HIV) … treatment failure and no resistance to either drug … rilpivirine injections. In another study, people who had difficulty taking pills … trials, to defend humans against HIV infection, treat HIV …
-
FDA Approves Rilpivirine For Treatment of HIV-1 in Pediatric Patients
21 Mar 2024 19:18 GMT
… ;s rilpivirine (Edurant Ped) has received FDA approval for treating HIV-1 in treatment … head of infectious diseases and vaccines at Johnson & Johnson, … rilpivirine and seek immediate medical help.
Rilpivirine (Edurant) was originally approved by the FDA …
-
FDA Approves Rilpivirine for Treatment of HIV for Pediatric Patients 2 and Older
21 Mar 2024 18:43 GMT
… FDA has approved rilpivirine (Edurant Ped; Johnson and Johnson) for the treatment of HIV … of Infectious Diseases and Vaccines at Johnson & … About The Clinical Trials
PICTURE Trial
Trial Name: A Study …
The PICTURE trial evaluated the drug for individuals …
-
FDA Approves EDURANT PED (rilpivirine) for Certain Pediatric Patients Living with HIV-1
21 Mar 2024 15:02 GMT
… and Drug Administration (FDA) has approved EDURANT PED (rilpivirine) for the treatment of HIV-1 … Area Head, Infectious Diseases and Vaccines at Johnson & Johnson. “While …
-
FDA approves rilpivirine for pediatric patients with HIV-1, weighing 14 kg to 25 kg
20 Mar 2024 19:22 GMT
… FDA has approved rilpivirine (EDURANT PED; Johnson & Johnson) to treat HIV … rilpivirine effectively suppressed the virus in treatment-naïve pediatric patients with HIV … Diseases and Vaccines, Johnson … medicines, they should not take rilpivirine …
-
Johnson & Johnson’s paediatric HIV-1 treatment secures FDA approval
20 Mar 2024 12:24 GMT
… US Food and Drug Administration (FDA) approval for … rilpivirine is a nonnucleoside reverse transcriptase inhibitor designed specifically for the treatment … of HIV-1.
Access … infectious diseases and vaccines global therapeutic area …